Maura Abbott

804 total citations · 1 hit paper
16 papers, 561 citations indexed

About

Maura Abbott is a scholar working on Oncology, Clinical Psychology and Immunology. According to data from OpenAlex, Maura Abbott has authored 16 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 4 papers in Clinical Psychology and 3 papers in Immunology. Recurrent topics in Maura Abbott's work include COVID-19 and healthcare impacts (5 papers), COVID-19 and Mental Health (4 papers) and Cancer survivorship and care (3 papers). Maura Abbott is often cited by papers focused on COVID-19 and healthcare impacts (5 papers), COVID-19 and Mental Health (4 papers) and Cancer survivorship and care (3 papers). Maura Abbott collaborates with scholars based in United States, Switzerland and Canada. Maura Abbott's co-authors include Yelena Ustoyev, Christine Miaskowski, Karin Snowberg, Katherine Van Loon, Marilyn J. Hammer, Stacey A. Kenfield, Steven M. Paul, Rachel Pozzar, Jon D. Levine and Bevin Cohen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Pain and Symptom Management.

In The Last Decade

Maura Abbott

15 papers receiving 551 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer and the Immune System: The History and Background of Immunotherapy

2019 351 citations Maura Abbott, Yelena Ustoyev Seminars in Oncology Nursing profile →

Peers

Maura Abbott

ONCOL

IMMUN

MB

PRM

CP

Rosa de Groot Netherlands

Olivia Le Saux France

Ling Yuan Kong Canada

Federica Mazzuca Italy

Hui‐Chun Hsu Taiwan

Fei Tong China

Qin Cheng China

Witold Owczarek Poland

Kyoji Ogoshi Japan

Rosa de Groot Netherlands

Maura Abbott

206 ×0.6

ONCOL

189 ×1.3

IMMUN

94 ×0.7

MB

59 ×0.7

PRM

25 ×0.4

CP

Citations per year, relative to Maura Abbott Maura Abbott (= 1×) peers Rosa de Groot

Countries citing papers authored by Maura Abbott

Since Specialization

Citations

This map shows the geographic impact of Maura Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maura Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maura Abbott more than expected).

Fields of papers citing papers by Maura Abbott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maura Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maura Abbott. The network helps show where Maura Abbott may publish in the future.

Co-authorship network of co-authors of Maura Abbott

This figure shows the co-authorship network connecting the top 25 collaborators of Maura Abbott. A scholar is included among the top collaborators of Maura Abbott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maura Abbott. Maura Abbott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Pozzar, Rachel, Bruce A. Cooper, Steven M. Paul, et al.. (2024). Worse Psychological Profiles Are Associated With Higher Levels of Stress and Symptom Burden in Patients With Cancer During the COVID-19 Pandemic. Oncology nursing forum. 51(6). 529–546. 1 indexed citations

2.

Paul, Steven M., Bruce A. Cooper, Maura Abbott, et al.. (2023). COVID-19 pandemic stress and cancer symptom burden. BMJ Supportive & Palliative Care. 13(e3). e1351–e1362.

3.

Miaskowski, Christine, Steven M. Paul, Karin Snowberg, et al.. (2021). Loneliness and symptom burden in oncology patients during the COVID‐19 pandemic. Cancer. 127(17). 3246–3253. 47 indexed citations

4.

Beauchemin, Melissa, Chunhua Weng, Lillian Sung, et al.. (2021). Data Quality of Chemotherapy-Induced Nausea and Vomiting Documentation. Applied Clinical Informatics. 12(2). 320–328. 4 indexed citations

5.

Wong, Winston, Michael May, Susan Whittier, et al.. (2020). A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy. Seminars in Oncology. 48(2). 166–170. 1 indexed citations

6.

Miaskowski, Christine, Steven M. Paul, Karin Snowberg, et al.. (2020). Oncology patients’ perceptions of and experiences with COVID-19. Supportive Care in Cancer. 29(4). 1941–1950. 22 indexed citations

7.

Miaskowski, Christine, Steven M. Paul, Karin Snowberg, et al.. (2020). Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic. Journal of Pain and Symptom Management. 60(5). e25–e34. 85 indexed citations

8.

Abbott, Maura, et al.. (2020). Breast Cancer Risk Related to Combined Oral Contraceptive Use. The Journal for Nurse Practitioners. 16(2). 116–120. 1 indexed citations

9.

Abbott, Maura & Yelena Ustoyev. (2019). Cancer and the Immune System: The History and Background of Immunotherapy. Seminars in Oncology Nursing. 35(5). 150923–150923. 351 indexed citations breakdown →

10.

O’Neil, Daniel S., Melissa Accordino, Jason D. Wright, et al.. (2019). Delay in receipt of newly prescribed oral anticancer drugs.. Journal of Clinical Oncology. 37(15_suppl). 6541–6541. 3 indexed citations

11.

O’Neil, Daniel S., Melissa Accordino, Jason D. Wright, et al.. (2019). Use of nonclinical staff to coordinate oral anticancer drug prescriptions.. Journal of Clinical Oncology. 37(27_suppl). 72–72. 1 indexed citations

12.

Abbott, Maura, et al.. (2016). Risk for Health Care–Associated Bloodstream Infections in Pediatric Oncology Patients With Various Malignancies. Journal of Pediatric Oncology Nursing. 34(3). 196–202. 11 indexed citations

13.

Schwartz, Gary K., Douglas Adkins, Rebecca S. Heist, et al.. (2015). A first-in-human phase I/Ib study of receptor tyrosine kinase (RTK) inhibitor, MGCD516, in patients with advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). TPS2621–TPS2621. 3 indexed citations

14.

Trivedi, Meghna S., et al.. (2015). Programmed death 1 immune checkpoint inhibitors.. PubMed. 13(12). 858–68. 23 indexed citations

15.

Abbott, Maura, et al.. (1982). Weight loss during therapy for advanced breast cancer.. PubMed. 8(1). 33–8. 7 indexed citations

16.

Coombes, R. Charles, et al.. (1980). The value of sequential marker estimations following mastectomy for breast cancer.. PubMed. Suppl 1. 25–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact